Grove Biopharma has raised a $30 million series A round to develop Bionic Biologics, also known as protein-like polymers (PLP ...

Experts express alarm that GLP-1 RAs may trigger or worsen eating disorders. But is there any role they might play in binge ...

Biological functions related to sleep and emotional processing are integral to human brain function but often remain ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.

Certain DNA sequences can form structures other than the canonical double helix. These alternative DNA conformations—referred ...

In Alzheimer's, Parkinson's, and type 2 diabetes, harmful protein aggregates and deposits, known as amyloid plaques, develop.

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), currently licensed for the treatment of type 2 diabetes mellitus and obesity, offer a novel, multilayered mechanism for intervention in ...

Share on Pinterest Common antidiabetes drugs could help lower Alzheimer’s risk, increasing evidence suggests. Image credit: mbbirdy/Getty Images. A new study investigates the relationship ...

Drucker and three co-winners made discoveries about glucagon-like peptide-1 in their labs. The other recipient of the award, Lotte Bjerre Knudsen, who works for Novo Nordisk, led the way in ...

Department of Materials Science and Chemical Engineering, Hanyang University, Ansan 15588, Republic of Korea Department of Materials Science and Engineering, Korea Advanced Institute of Science and ...

Drucker and three co-winners made discoveries about glucagon-like peptide-1 in their labs. The other recipient of the award, Lotte Bjerre Knudsen, who works for Novo Nordisk, led the way in ...